Home › Research › Inflammation and the immune system
The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease
McClean PL, Parthsarathy V, Faivre E, Hölscher C.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011-04-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Type 2 diabetes is a risk factor for Alzheimer's disease, most likely linked to an impairment of insulin signaling in the brain. The incretin hormone glucagon-like peptide-1 (GLP-1) facilitates insulin signaling, and novel long-lasting GLP-1 analogs, such as liraglutide, are on the market as diabetes therapeutics. GLP-1 has been shown to have neuroprotective properties in vitro and in vivo.
What this study adds
Evidence grade: Low
In a mouse model of Alzheimer's disease, the diabetes drug liraglutide was tested after being shown to cross the blood-brain barrier. Reported effect size: reduced by 25%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
McClean, P. L., Parthsarathy, V., Faivre, E., & Hölscher, C. (2011). The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. https://doi.org/10.1523/jneurosci.0529-11.2011
Vancouver
McClean PL, Parthsarathy V, Faivre E, Hölscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2011. doi:10.1523/jneurosci.0529-11.2011. PMID: 21525299.
BibTeX
@article{mcclean2011-21525299,
author = {McClean, P. L. and Parthsarathy, V. and Faivre, E. and Hölscher, C.},
title = {{The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease}},
journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
year = {2011},
doi = {10.1523/jneurosci.0529-11.2011},
pmid = {21525299},
url = {https://doi.org/10.1523/jneurosci.0529-11.2011}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The incretin hormone glucagon-like peptide-1 (GLP-1) facilitates insulin signaling, and novel long-lasting GLP-1 analogs, such as liraglutide, are on the market as diabetes therapeutics.
- GLP-1 has been shown to have neuroprotective properties in vitro and in vivo.
- Here we tested the effects of peripherally injected liraglutide in an Alzheimer mouse model, APP(swe)/PS1(ΔE9) (APP/PS1).
- Liraglutide was shown to cross the blood-brain barrier in an acute study.
Why it matters
In a mouse model of Alzheimer's disease, the diabetes drug liraglutide was tested after being shown to cross the blood-brain barrier. This is animal work only and reports no treatment, cure or prevention for people.
Study details
- Effect sizereduced by 25%
- Evidence strengthLow
How this study scored 51/100
Published in a peer-reviewed journal. Scored zero for study design, sample size and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The Journal of neuroscience : the official journal of the Society for Neuroscience) |
| Journal's citation record | 4 / 4 | Journal of Neuroscience: journal h-index 651 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2011 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Laboratory or animal study (title names “mouse”) — scores zero |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 695 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 40.9 citations a year over 17 year(s) since 2011 |
| Impact for its field and year | 5 / 6 | Cited 32.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 18 other studies in this library |
| Still being cited | 3 / 4 | Cited 126 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Christian Hölscher: h-index 86 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Ulster: institution h-index 418 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 21525299) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1523/jneurosci.0529-11.2011
- PubMed: 21525299
- Original source →
- Free full text: Journal of Neuroscience →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
18 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Inflammation and the immune system from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.